S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
CLOSED · 21:40 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead
BS
INSIDER · FDMT · 4D Molecular Therapeutics, Inc. · CHIEF LEGAL OFFICER

Bizily Scott

Every open-market transaction filed under this name, Sep 1 to Oct 16.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$51K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 16FDMT4D Molecular Therapeutics, Inc.Chief Legal OfficerSell1,635$12.84$21K−1.7%
Sep 16FDMT4D Molecular Therapeutics, Inc.Chief Legal OfficerSell1,635$13.65$22K−7.5%
Sep 1FDMT4D Molecular Therapeutics, Inc.Chief Legal OfficerSell584$14.00$8K−9.9%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.